Overall Survival with Maintenance Olaparib at a 7-Year Follow-up in Patients with Newly Diagnosed Advanced Ovarian Cancer and a BRCA Mutation: The SOLO1/GOG 3004 Trial

SOLO1 Investigators

    Research output: Contribution to journalComment/debate

    4 Citations (Scopus)
    Original languageEnglish
    Pages (from-to)25-27
    Number of pages3
    JournalObstetrical and Gynecological Survey
    Volume78
    Issue number1
    DOIs
    Publication statusPublished - 1 Jan 2023

    Cite this